Cargando…
Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients
Tumor molecular profiling is a fundamental component of precision oncology, enabling the identification of genomic alterations in genes and pathways that can be targeted therapeutically. The existence of recurrent targetable alterations across distinct histologically-defined tumor types, coupled wit...
Ejemplares similares
-
Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing
por: Cheng, Donavan T., et al.
Publicado: (2017) -
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
por: Ptashkin, Ryan N., et al.
Publicado: (2023) -
Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma
por: Zhu, Guo, et al.
Publicado: (2018) -
The molecular landscape of extraskeletal osteosarcoma: A clinicopathological and molecular biomarker study
por: Jour, George, et al.
Publicado: (2015) -
Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
por: Rose Brannon, A., et al.
Publicado: (2021)